Cerebral blood flow effects of sodium valproate in drug combinations in the baboon model

Arzneimittel-Forschung/Drug Research

Volumn 48, Issue 11, 1998, Pages 1058-1063

  Oliver, Douglas W ^a   Dormehl, Irene C ^b  

^a NORTH WEST UNIVERSITY   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Acetazolamide; CAS 1069 66 5; Epitim ; Nimodipine; Sodium valproate, cerebral blood flow effects, drug interactions, primate model; Sumatriptan

Indexed keywords

ACETAZOLAMIDE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; KETAMINE; NIMODIPINE; SUMATRIPTAN; THIOPENTAL; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABOON; BRAIN BLOOD FLOW; CONTROLLED STUDY; DRUG EFFECT; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; SEIZURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ACETAZOLAMIDE; ANIMALS; ANTICONVULSANTS; CARBONIC ANHYDRASE INHIBITORS; CEREBROVASCULAR CIRCULATION; DRUG INTERACTIONS; HEMODYNAMIC PROCESSES; MALE; NIMODIPINE; PAPIO; RADIOPHARMACEUTICALS; SUMATRIPTAN; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VALPROIC ACID; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0031786985     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. th Edition, J. G. Hardman, L. E. Limbird, P. B. Molinoff et al., (eds.), pp. 476, McGraw-Hill, New York (1996)
2. Chapman, A., Keane, P. E., Meldrun, B. S. et al., Prog. Neurobiol. 19, 315 (1982)
3. Phillips, N. I., Fowler, L. J., Biochem. Pharmacol. 31, 2257 (1982)
4. Mclean, M. J., Macdonald, R. L., J. Pharmacol. Exp. Ther. 238, 727 (1986)
5. Coulter, D. A., Huguenard, J. R., Prince, D. A., Br. J. Pharmacol. 100, 800 (1990)
6. Dormehl, I. C., Redelinghuys, F., Hugo, N. et al., J. Med. Primatol. 21, 270 (1992)
7. Dormehl, I. C., Oliver, D. W., Hugo, N., Nucl. Med. Commun. 14, 573 (1993)
8. Dormehl, I. C., Lipp, M. D. W., Hugo, N. et al., Eur. J. Nucl. Med. 20, 11 (1993)
9. Oliver, D. W., Dormehl, I. C., Redelinghuys, F. et al., Nukl. Med. 32, 292 (1993)
10. Oliver, D. W., Dormehl, I. C., Hugo, N., Arzneim.-Forsch./Drug Res. 44 (II), 925 (1994)
11. Jordaan, B., Oliver, D. W., Dormehl, I. C. et al., Arzneim.-Forsch./Drug Res. 46 (II), 844 (1996)
12. Futagi, Y., Otani, K., Imai, K., Epilepsia 35, 827 (1994)
13. Feggi, L., Scarpa, P. Calzolari, F., Clin. Nucl. Med. 20, 42 (1995)
14. Spenser, S. S., Epilepsia, 35, 72 (1994)
15. Nehlig, A., Vergnes, M., Waydedlich, R. et al., J. Cereb. Blood Flow Metab. 16, 147 (1996)
16. Newton, M. R., Berkovic, S. F., Austin, M. C. et al., Eur. J. Nucl. Med. 21, 1067 (1994)
17. Wieser, H. G., Eur. Neurol. 34, 58 (1994)
18. Ogasawara, K., Fujiwara, S., Yoshimoto, T., Kaku Igaku (Japan) 32, 1241 (1995)
19. Dormehl, I. C., Oliver, D. W., Hugo, N., Arzneim.-Forsch./Drug Res. 45 (II), 952 (1995)
20. Lassen, N. A., Christensen, M. S., Br. J. Anaesth. 48, 719 (1976)
21. Wood, M., Wood, A. J. J., Drugs Anaesth. 2, 179 (1990)
22. Langley, M. S., Sorkin, E. M., Drugs 27, 669 (1989)